Dosing begins in trial of AlloNK, NK cell therapy for lupus nephritis
The first patient was dosed in the U.S. as part of a clinical trial testing of NK cell therapy candidate AlloNK for lupus nephritis.| Lupus News Today
The first patient was dosed in the U.S. as part of a clinical trial testing of NK cell therapy candidate AlloNK for lupus nephritis.| Lupus News Today
